Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
Bausch Health Companies press release ( NYSE: BHC ): Q3 GAAP EPS of $1.10. Revenue of $2.05B (-2.8% Y/Y). 2022 Financial Outlook Full year revenue range of $8.0 - $8.17 billion compared with prior guidance of $8.05 - $8.22 billion Full year revenues flat to...
Revenues of $2.046 billion, down 3% reported, up 2% organic basis Third quarter sales improved sequentially, notably Salix, International, and Solta Successful debt exchange offer reduces debt by $2.5 billion Company updates full year guidance LAVAL, QC / ACCESSWIRE / No...
Bausch Health Companies ( NYSE: BHC ) is scheduled to announce Q3 earnings results on Thursday, November 3rd, before market open. The consensus EPS Estimate is $0.78 (+50.0% Y/Y) and the consensus Revenue Estimate is $2.06B (-2.4% Y/Y). Over the last 2 years, BHC has...
Nine Poster Presentations Include New Analyses of SILIQ ® and JUBLIA ® LAVAL, QC / ACCESSWIRE / November 1, 2022 / - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the presentation of ni...
New Educational Resource Designed to Help Support the Podiatry Community Company Also Adds 300 Questions to Existing Dermatology Board Review Challenge LAVAL, QC / ACCESSWIRE / October 31, 2022 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology...
LAVAL, QC / ACCESSWIRE / October 24, 2022 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals ("Salix"), today announced four posters and one abstract featuring data for XIFAXAN® (rifaximin), TRULANCE® (pleca...
Eleven Poster Presentations Include New Analyses of ARAZLO®, DUOBRII®, and IDP-126 Gel LAVAL, QC / ACCESSWIRE / October 20, 2022 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the presenta...
LAVAL, QC / ACCESSWIRE / October 13, 2022 / Bausch Health Companies Inc. (NYSE/TSX:BHC) ("Bausch Health") will release its third quarter financial results on Thursday, Nov. 3, 2022. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and pr...
Summary Calamos offers seven different closed-end funds, all with some overlap. CHY and CHI seem to have the most overlap of the group. Today, we are looking at just how similar they are and deciding if either is a better deal at this time. Written by Nick Ackerman, co...
SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION PR Newswire Released During Liver Health Awareness Month and Based Primarily on HCP-Market Research, ...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...